NCT05154162 2026-03-03
PRIMARY2
Peter MacCallum Cancer Centre, Australia
Phase 3 Active not recruiting
Clinical Trials
197 trialsNCT05051735 2026-02-25
PARASTOP
Oslo University Hospital
Phase 3 Completed
NCT05804032 2026-02-18
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
Phase 3 Completed
NCT07005024 2026-02-05
DOAC
University of Vermont
Phase 3 Recruiting
NCT03979014 2026-01-29
NOVEL
Imperial College London
Phase 3 Completed
NCT05223647 2026-01-28
TRIPLEX
Norwegian University of Science and Technology
Phase 3 Terminated
NCT07366528 2026-01-26
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
Phase 3 Recruiting
NCT05053867 2026-01-14
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT06881992 2025-12-30
Tumor HI
Rezolute
Phase 3 Recruiting
NCT07290491 2025-12-18
SPC
The Methodist Hospital Research Institute
Phase 3 Recruiting
NCT07287592 2025-12-17
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University
Phase 3 Not yet recruiting
NCT06905587 2025-12-11
EMBRAIN
Odense University Hospital
Phase 3 Recruiting
NCT02967289 2025-11-17
IROCAS
UNICANCER
Phase 3 Completed
NCT01579552 2025-11-12
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Active not recruiting
NCT01169259 2025-11-06
VITAL
Brigham and Women's Hospital
Phase 3 Active not recruiting
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT07207824 2025-10-06
HERO
Fudan University
Phase 3 Not yet recruiting
NCT05335928 2025-09-10
ATRIUM
Massachusetts General Hospital
Phase 3 Recruiting
NCT04534075 2025-09-08
FIDURA
Sahlgrenska University Hospital
Phase 3 Completed
NCT03741673 2025-09-05
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT02330926 2025-08-29
MENAC
Norwegian University of Science and Technology
Phase 3 Completed
NCT07067749 2025-07-24
TEMPO-MIBC
University of Rome Tor Vergata
Phase 3 Recruiting
NCT02885753 2025-07-09
OSCAR
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT05029063 2025-07-09
TRIM-Line
Ottawa Hospital Research Institute
Phase 3 Recruiting
NCT05454280 2025-07-08
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Fox Chase Cancer Center
Phase 3 Recruiting
NCT04616768 2025-07-02
PROStep
Abramson Cancer Center at Penn Medicine
Phase 3 Completed
NCT07035821 2025-06-25
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Shanghai Children's Medical Center
Phase 3 Not yet recruiting
NCT01804790 2025-06-12
Néofirinox
UNICANCER
Phase 3 Completed
NCT02804815 2025-06-10
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Phase 3 Active not recruiting
NCT06768164 2025-05-14
BYQoL-GC
Assistance Publique - Hôpitaux de Paris
Phase 3 Not yet recruiting
NCT03603184 2025-05-09
AtTEnd
Mario Negri Institute for Pharmacological Research
Phase 3 Completed
NCT03578081 2025-04-06
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT06127654 2025-04-04
VITaL
University of Sydney
Phase 3 Not yet recruiting
NCT04711109 2025-04-02
BRCA-P
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT06859190 2025-03-25
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Qinghai Red Cross Hospital
Phase 3 Recruiting
NCT05899465 2025-03-18
PRIME
University of Aarhus
Phase 3 Recruiting
NCT00446225 2025-03-05
EURTAC
Spanish Lung Cancer Group
Phase 3 Completed
NCT06836492 2025-02-20
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Sun Yat-sen University
Phase 3 Recruiting
NCT03692065 2025-02-06
API-CAT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT03839940 2025-01-29
MIST
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT00798070 2024-12-18
PANTHER
Karolinska University Hospital
Phase 3 Active not recruiting
NCT01957436 2024-11-12
PEACE1
UNICANCER
Phase 3 Active not recruiting
NCT05939687 2024-08-07
ProMeLAR
Blokhin's Russian Cancer Research Center
Phase 3 Recruiting
NCT06500234 2024-07-15
Nutrition Impact on Immunotherapy of Cancer
Qingdao Central Hospital
Phase 3 Recruiting
NCT03506815 2024-07-05
TRIM-Line
Ottawa Hospital Research Institute
Phase 3 Completed
NCT03837171 2024-06-25
TRANSPORT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT01788020 2024-05-13
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
University of Ulm
Phase 3 Completed
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT01822314 2024-03-07
ETNA
Fondazione Michelangelo
Phase 3 Completed
NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown